U.S. Thrombectomy Devices Market by Technology (Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, and Rheolytic Thrombectomy Devices), Type (Automated Thrombectomy Devices and Manual Thrombectomy Devices), Disease (Neurovascular Thrombectomy Devices, Peripheral Thrombectomy Devices, and Coronary Thrombectomy Devices), and Utility (Reusable Thrombectomy Devices and Disposable Thrombectomy Devices): Opportunity Analysis and Industry Forecast, 2018 - 2025
U.S. Thrombectomy Devices Market Overview:
Thrombectomy is the surgical removal of blood clot from a blood vessel. Deep vein thrombosis is a life-threatening disease where blood clots within a vein. These clots can pass through to arteries or veins in different body parts—brain, heart, kidneys, lungs, and limbs. Similarly, venous thromboembolism (VTE) is considered as the cause of heart attack and stroke; however, it can damage body organs or may even lead to death. VTE results due to various factors such as combination of hereditary and acquired risk factors. It can be diagnosed in smoking population and people who consume estrogens or birth control pills. VTE is highly prevalent in adults (>60 years), however, can occur at any age.
The U.S. thrombectomy devices market is was valued at $501.9 million in 2017, and is estimated to garner $750.4 million by 2025, registering a significant CAGR of 5.1% from 2018 to 2025. This is attributed to increase in incidence of acute myocardial infarction (AMI), peripheral artery disease (PAD), deep vein thrombosis (DVT), and pulmonary embolism (PE), due to sedentary lifestyle and unhealthy living conditions & habits along with rise in geriatric population in the U.S. Moreover, increase in incidence of cardiovascular diseases, surge in demand for minimally invasive procedures, rise in need for sophisticated healthcare infrastructure; and increase in market competition have led to technological advancements and innovations. However, lack of trained professionals & awareness and complicated use of these devices restrict the market growth. On the contrary, introduction of lasers & UV radiation and 3D imaging generation in thrombectomy devices is anticipated to provide lucrative growth opportunities to market players in the near future.
The U.S. thrombectomy devices market is segmented based on technology, type, utility, and disease. Depending on the type of technology, the market is categorized into mechanical, aspiration, and rheolytic thrombectomy devices. By type, it is bifurcated into automated and manual thrombectomy devices. As per utility, it is classified into reusable and disposable thrombectomy devices. On the basis of disease, it is divided into peripheral, neurovascular, and coronary thrombectomy devices.
Key Benefits for U.S. Thrombectomy Devices Market:
The U.S. thrombectomy report provides an extensive analysis of the current market trends and future estimations of the market.
The market scenario is comprehensively analyzed with respect to the technology, type, utility, and disease.
The U.S. thrombectomy devices market growth estimations in this report are based on high-end analysis of the key developments for 2018–2025.
Recent developments, key manufacturers, and market shares are listed in this report to analyze the competitive scenario of the market.
U.S. Thrombectomy Devices Key Market Segments:
By Technology
Mechanical Thrombectomy Devices
Aspiration Thrombectomy Devices
Rheolytic Thrombectomy Devices
By Type
Automated Thrombectomy Devices
Manual Thrombectomy Devices
By Disease
Peripheral Thrombectomy Devices
Coronary Thrombectomy Devices
Neural Thrombectomy Devices
By Utility
Reusable Thrombectomy Devices
Disposable Thrombectomy Devices
Key Market Players
Boston Scientific Corporation
Medtronic plc
Teleflex Incorporated
Penumbra, Inc.
Koninklijke Philips N.V.
AngioDynamics, Inc.
Terumo Corporation
Johnson and Johnson
Stryker Corporation
Capture Vascular, Inc.
The other players in the value chain include (profiles not included in the report)
Argon Medical Devices, Inc.
Inari Medical, Inc.
Thrombectomy is the surgical removal of blood clot from a blood vessel. Deep vein thrombosis is a life-threatening disease where blood clots within a vein. These clots can pass through to arteries or veins in different body parts—brain, heart, kidneys, lungs, and limbs. Similarly, venous thromboembolism (VTE) is considered as the cause of heart attack and stroke; however, it can damage body organs or may even lead to death. VTE results due to various factors such as combination of hereditary and acquired risk factors. It can be diagnosed in smoking population and people who consume estrogens or birth control pills. VTE is highly prevalent in adults (>60 years), however, can occur at any age.
The U.S. thrombectomy devices market is was valued at $501.9 million in 2017, and is estimated to garner $750.4 million by 2025, registering a significant CAGR of 5.1% from 2018 to 2025. This is attributed to increase in incidence of acute myocardial infarction (AMI), peripheral artery disease (PAD), deep vein thrombosis (DVT), and pulmonary embolism (PE), due to sedentary lifestyle and unhealthy living conditions & habits along with rise in geriatric population in the U.S. Moreover, increase in incidence of cardiovascular diseases, surge in demand for minimally invasive procedures, rise in need for sophisticated healthcare infrastructure; and increase in market competition have led to technological advancements and innovations. However, lack of trained professionals & awareness and complicated use of these devices restrict the market growth. On the contrary, introduction of lasers & UV radiation and 3D imaging generation in thrombectomy devices is anticipated to provide lucrative growth opportunities to market players in the near future.
The U.S. thrombectomy devices market is segmented based on technology, type, utility, and disease. Depending on the type of technology, the market is categorized into mechanical, aspiration, and rheolytic thrombectomy devices. By type, it is bifurcated into automated and manual thrombectomy devices. As per utility, it is classified into reusable and disposable thrombectomy devices. On the basis of disease, it is divided into peripheral, neurovascular, and coronary thrombectomy devices.
Key Benefits for U.S. Thrombectomy Devices Market:
The U.S. thrombectomy report provides an extensive analysis of the current market trends and future estimations of the market.
The market scenario is comprehensively analyzed with respect to the technology, type, utility, and disease.
The U.S. thrombectomy devices market growth estimations in this report are based on high-end analysis of the key developments for 2018–2025.
Recent developments, key manufacturers, and market shares are listed in this report to analyze the competitive scenario of the market.
U.S. Thrombectomy Devices Key Market Segments:
By Technology
Mechanical Thrombectomy Devices
Aspiration Thrombectomy Devices
Rheolytic Thrombectomy Devices
By Type
Automated Thrombectomy Devices
Manual Thrombectomy Devices
By Disease
Peripheral Thrombectomy Devices
Coronary Thrombectomy Devices
Neural Thrombectomy Devices
By Utility
Reusable Thrombectomy Devices
Disposable Thrombectomy Devices
Key Market Players
Boston Scientific Corporation
Medtronic plc
Teleflex Incorporated
Penumbra, Inc.
Koninklijke Philips N.V.
AngioDynamics, Inc.
Terumo Corporation
Johnson and Johnson
Stryker Corporation
Capture Vascular, Inc.
The other players in the value chain include (profiles not included in the report)
Argon Medical Devices, Inc.
Inari Medical, Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. Top player positioning, 2017
3.4. Porters five forces analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. High prevalence of PDA, AMI, DVT, and PE
3.5.1.2. Surge in demand for minimally invasive procedures
3.5.1.3. Technological advancements & innovations
3.5.2. Restraints
3.5.2.1. High cost and complications associated with the use of thrombectomy devices
3.5.2.2. Dearth of trained professionals & lack of awareness
3.5.3. Opportunities
3.5.3.1. Introduction of lasers and UV radiation as well as 3D imaging generation in thrombectomy devices
3.5.3.2. Combination of decompressive surgery and thrombectomy
CHAPTER 4: U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Mechanical thrombectomy devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Aspiration thrombectomy devices
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. Rheolytic thrombectomy devices
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
CHAPTER 5: U.S. THROMBECTOMY DEVICES MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Automated thrombectomy devices
5.2.1. Market size and forecast
5.3. Manual thrombectomy devices
5.3.1. Market size and forecast
CHAPTER 6: U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE
6.1. Overview
6.1.1. Market size and forecast
6.2. Neurovascular thrombectomy devices
6.2.1. Market size and forecast
6.3. Peripheral thrombectomy devices
6.3.1. Market size and forecast
6.4. Coronary thrombectomy devices
6.4.1. Market size and forecast
CHAPTER 7: U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY
7.1. Overview
7.1.1. Market size and forecast
7.2. Reusable thrombectomy devices
7.2.1. Market size and forecast
7.3. Disposable thrombectomy devices
7.3.1. Market size and forecast
CHAPTER 8: COMPANY PROFILES
8.1. BOSTON SCIENTIFIC CORPORATION
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. JOHNSON & JOHNSON
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. MEDTRONIC PLC
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Stryker Corporation
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic move and development
8.5. Teleflex Incorporated
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic move and development
8.6. TERUMO MEDICAL CORPORATION
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic move and development
8.7. KONINKLIJKE PHILIPS N.V.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Product portfolio
8.7.6. Key strategic moves and developments
8.8. Angiodynamics Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product Portfolio
8.8.5. Business performance
8.9. Penumbra, Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product Portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Capture Vascular, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. Top player positioning, 2017
3.4. Porters five forces analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. High prevalence of PDA, AMI, DVT, and PE
3.5.1.2. Surge in demand for minimally invasive procedures
3.5.1.3. Technological advancements & innovations
3.5.2. Restraints
3.5.2.1. High cost and complications associated with the use of thrombectomy devices
3.5.2.2. Dearth of trained professionals & lack of awareness
3.5.3. Opportunities
3.5.3.1. Introduction of lasers and UV radiation as well as 3D imaging generation in thrombectomy devices
3.5.3.2. Combination of decompressive surgery and thrombectomy
CHAPTER 4: U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Mechanical thrombectomy devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Aspiration thrombectomy devices
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. Rheolytic thrombectomy devices
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
CHAPTER 5: U.S. THROMBECTOMY DEVICES MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Automated thrombectomy devices
5.2.1. Market size and forecast
5.3. Manual thrombectomy devices
5.3.1. Market size and forecast
CHAPTER 6: U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE
6.1. Overview
6.1.1. Market size and forecast
6.2. Neurovascular thrombectomy devices
6.2.1. Market size and forecast
6.3. Peripheral thrombectomy devices
6.3.1. Market size and forecast
6.4. Coronary thrombectomy devices
6.4.1. Market size and forecast
CHAPTER 7: U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY
7.1. Overview
7.1.1. Market size and forecast
7.2. Reusable thrombectomy devices
7.2.1. Market size and forecast
7.3. Disposable thrombectomy devices
7.3.1. Market size and forecast
CHAPTER 8: COMPANY PROFILES
8.1. BOSTON SCIENTIFIC CORPORATION
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. JOHNSON & JOHNSON
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. MEDTRONIC PLC
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Stryker Corporation
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic move and development
8.5. Teleflex Incorporated
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic move and development
8.6. TERUMO MEDICAL CORPORATION
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic move and development
8.7. KONINKLIJKE PHILIPS N.V.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Product portfolio
8.7.6. Key strategic moves and developments
8.8. Angiodynamics Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product Portfolio
8.8.5. Business performance
8.9. Penumbra, Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product Portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Capture Vascular, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
LIST OF TABLES
TABLE 01. U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 20172025 ($MILLION)
TABLE 02. U.S. THROMBECTOMY DEVICES MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 03. U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE, 20172025 ($MILLION)
TABLE 04. U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY, 20172025 ($MILLION)
TABLE 05. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 06. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 07. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 08. J&J: COMPANY SNAPSHOT
TABLE 09. J&J: OPERATING SEGMENTS
TABLE 10. J&J: PRODUCT PORTFOLIO
TABLE 11. MEDTRONIC: COMPANY SNAPSHOT
TABLE 12. MEDTRONIC: OPERATING SEGMENTS
TABLE 13. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 14. STRYKER: COMPANY SNAPSHOT
TABLE 15. STRYKER: OPERATING SEGMENTS
TABLE 16. STRYKER: PRODUCT PORTFOLIO
TABLE 17. TELEFLEX: COMPANY SNAPSHOT
TABLE 18. TELEFLEX: OPERATING SEGMENTS
TABLE 19. TELEFLEX: PRODUCT PORTFOLIO
TABLE 20. TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 21. TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 22. TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 23. PHILIPS: COMPANY SNAPSHOT
TABLE 24. PHILIPS: OPERATING SEGMENTS
TABLE 25. PHILIPS: PRODUCT PORTFOLIO
TABLE 26. ANGIODYNAMICS INC.: COMPANY SNAPSHOT
TABLE 27. ANGIODYNAMICS INC: OPERATING SEGMENTS
TABLE 28. ANGIODYNAMICS INC.: PRODUCT PORTFOLIO
TABLE 29. PENUMBRA, INC.: COMPANY SNAPSHOT
TABLE 30. PENUMBRA INC: OPERATING SEGMENTS
TABLE 31. PENUMBRA, INC.: PRODUCT PORTFOLIO
TABLE 32. CAPTURE VASCULAR, INC.: COMPANY SNAPSHOT
TABLE 33. CAPTURE VASCULAR, INC.: OPERATING BUSINESS SEGMENTS
TABLE 34. CAPTURE VASCULAR, INC: PRODUCT PORTFOLIO
TABLE 01. U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 20172025 ($MILLION)
TABLE 02. U.S. THROMBECTOMY DEVICES MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 03. U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE, 20172025 ($MILLION)
TABLE 04. U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY, 20172025 ($MILLION)
TABLE 05. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 06. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 07. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 08. J&J: COMPANY SNAPSHOT
TABLE 09. J&J: OPERATING SEGMENTS
TABLE 10. J&J: PRODUCT PORTFOLIO
TABLE 11. MEDTRONIC: COMPANY SNAPSHOT
TABLE 12. MEDTRONIC: OPERATING SEGMENTS
TABLE 13. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 14. STRYKER: COMPANY SNAPSHOT
TABLE 15. STRYKER: OPERATING SEGMENTS
TABLE 16. STRYKER: PRODUCT PORTFOLIO
TABLE 17. TELEFLEX: COMPANY SNAPSHOT
TABLE 18. TELEFLEX: OPERATING SEGMENTS
TABLE 19. TELEFLEX: PRODUCT PORTFOLIO
TABLE 20. TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 21. TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 22. TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 23. PHILIPS: COMPANY SNAPSHOT
TABLE 24. PHILIPS: OPERATING SEGMENTS
TABLE 25. PHILIPS: PRODUCT PORTFOLIO
TABLE 26. ANGIODYNAMICS INC.: COMPANY SNAPSHOT
TABLE 27. ANGIODYNAMICS INC: OPERATING SEGMENTS
TABLE 28. ANGIODYNAMICS INC.: PRODUCT PORTFOLIO
TABLE 29. PENUMBRA, INC.: COMPANY SNAPSHOT
TABLE 30. PENUMBRA INC: OPERATING SEGMENTS
TABLE 31. PENUMBRA, INC.: PRODUCT PORTFOLIO
TABLE 32. CAPTURE VASCULAR, INC.: COMPANY SNAPSHOT
TABLE 33. CAPTURE VASCULAR, INC.: OPERATING BUSINESS SEGMENTS
TABLE 34. CAPTURE VASCULAR, INC: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. U.S. THROMBECTOMY DEVICE MARKET SEGMENTATION
FIGURE 02. TOP WINNING STRATEGIES, 20152018
FIGURE 03. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 20152018
FIGURE 04. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 05. TOP INVESTMENT POCKETS
FIGURE 06. TOP PLAYER POSITIONING, 2017
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE THREAT OF SUBSTITUTION
FIGURE 11. HIGH COMPETITIVE RIVALRY
FIGURE 12. MARKET DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13. U.S. THROMBECTOMY DEVICES MARKET FOR MECHANICAL THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 14. U.S. THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 15. U.S. THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 16. U.S. THROMBECTOMY DEVICES MARKET FOR AUTOMATED DEVICES, 20172025 ($MILLION)
FIGURE 17. U.S. THROMBECTOMY DEVICES MARKET FOR MANUAL THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 18. U.S. THROMBECTOMY DEVICES MARKET FOR NEUROVASCULAR THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 19. U.S. THROMBECTOMY DEVICES MARKET FOR PERIPHERAL THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 20. U.S. THROMBECTOMY DEVICES MARKET FOR CORONARY THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 21. U.S. THROMBECTOMY DEVICES MARKET FOR REUSABLE THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 22. U.S. THROMBECTOMY DEVICES MARKET FOR DISPOSABLE THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 23. BOSTON SCIENTIFIC: NET SALES, 20152017 ($MILLION)
FIGURE 24. BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 25. BOSTON SCIENTIFIC: NET SALES, BY REGION, 2017 (%)
FIGURE 26. J&J: NET SALES, 20152017 ($MILLION)
FIGURE 27. J&J: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 28. J&J: REVENUE SHARE, BY REGION, 2017 (%)
FIGURE 29. MEDTRONIC: NET SALES, 20152017 ($MILLION)
FIGURE 30. MEDTRONIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 31. MEDTRONIC: NET SALES, BY REGION, 2017 (%)
FIGURE 32. STRYKER: NET SALES, 20152017 ($MILLION)
FIGURE 33. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 34. STRYKER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 35. TELEFLEX: NET SALES, 20152017 ($MILLION)
FIGURE 36. TELEFLEX: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 37. TERUMO MEDICAL CORPORATION: NET SALES, 20152017 ($MILLION)
FIGURE 38. TERUMO MEDICAL CORPORATION: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 39. TERUMO MEDICAL CORPORATION: REVENUE SHARE BY REGION, 2016 (%)
FIGURE 40. PHILIPS: NET SALES, 20152017 ($MILLION)
FIGURE 41. PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 42. PHILIPS: REVENUE SHARE BY REGION, 2017(%)
FIGURE 43. ANGIODYNAMICS INC: REVENUE, 20162018 ($MILLION)
FIGURE 44. ANGIODYNAMICS INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 45. ANGIODYNAMICS INC.: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 46. PENUMBRA, INC.: REVENUE, 20162018 ($MILLION)
FIGURE 47. PENUMBRA, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. PENUMBRA, INC.: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 01. U.S. THROMBECTOMY DEVICE MARKET SEGMENTATION
FIGURE 02. TOP WINNING STRATEGIES, 20152018
FIGURE 03. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 20152018
FIGURE 04. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 05. TOP INVESTMENT POCKETS
FIGURE 06. TOP PLAYER POSITIONING, 2017
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE THREAT OF SUBSTITUTION
FIGURE 11. HIGH COMPETITIVE RIVALRY
FIGURE 12. MARKET DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13. U.S. THROMBECTOMY DEVICES MARKET FOR MECHANICAL THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 14. U.S. THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 15. U.S. THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 16. U.S. THROMBECTOMY DEVICES MARKET FOR AUTOMATED DEVICES, 20172025 ($MILLION)
FIGURE 17. U.S. THROMBECTOMY DEVICES MARKET FOR MANUAL THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 18. U.S. THROMBECTOMY DEVICES MARKET FOR NEUROVASCULAR THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 19. U.S. THROMBECTOMY DEVICES MARKET FOR PERIPHERAL THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 20. U.S. THROMBECTOMY DEVICES MARKET FOR CORONARY THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 21. U.S. THROMBECTOMY DEVICES MARKET FOR REUSABLE THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 22. U.S. THROMBECTOMY DEVICES MARKET FOR DISPOSABLE THROMBECTOMY DEVICES, 20172025 ($MILLION)
FIGURE 23. BOSTON SCIENTIFIC: NET SALES, 20152017 ($MILLION)
FIGURE 24. BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 25. BOSTON SCIENTIFIC: NET SALES, BY REGION, 2017 (%)
FIGURE 26. J&J: NET SALES, 20152017 ($MILLION)
FIGURE 27. J&J: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 28. J&J: REVENUE SHARE, BY REGION, 2017 (%)
FIGURE 29. MEDTRONIC: NET SALES, 20152017 ($MILLION)
FIGURE 30. MEDTRONIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 31. MEDTRONIC: NET SALES, BY REGION, 2017 (%)
FIGURE 32. STRYKER: NET SALES, 20152017 ($MILLION)
FIGURE 33. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 34. STRYKER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 35. TELEFLEX: NET SALES, 20152017 ($MILLION)
FIGURE 36. TELEFLEX: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 37. TERUMO MEDICAL CORPORATION: NET SALES, 20152017 ($MILLION)
FIGURE 38. TERUMO MEDICAL CORPORATION: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 39. TERUMO MEDICAL CORPORATION: REVENUE SHARE BY REGION, 2016 (%)
FIGURE 40. PHILIPS: NET SALES, 20152017 ($MILLION)
FIGURE 41. PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 42. PHILIPS: REVENUE SHARE BY REGION, 2017(%)
FIGURE 43. ANGIODYNAMICS INC: REVENUE, 20162018 ($MILLION)
FIGURE 44. ANGIODYNAMICS INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 45. ANGIODYNAMICS INC.: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 46. PENUMBRA, INC.: REVENUE, 20162018 ($MILLION)
FIGURE 47. PENUMBRA, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. PENUMBRA, INC.: REVENUE SHARE BY REGION, 2017 (%)
